ERBB2 and breast cancer: After FDR correction, histological grade, primary T category, HR status, ER status, PR status, Ki-67 status, and molecular subtype were statistically significant between HER2-positive and HER2-negative breast cancer patients in the training set (FDR-adjusted p-values ≤0.05).